Skip to main content

Technological offer

Available technologies catalogue

Available Technological Offer

Technological category
Recombinant chimeric antigen used for the prevention or treatment of infections caused by Anaplasma phagocytophilum.
Live attenuated vaccine incorporating a variant of the Rift Valley Fever virus obtained in the laboratory by serial passages in the presence of a mutagenic agent, that could be the basis of a new vaccine strain with safety parameters not previously described.

Social Media